These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23874525)

  • 101. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis.
    Li Q; Dong Z; Lin Y; Jia X; Li Q; Jiang H; Wang L; Gao Y
    PLoS One; 2013; 8(7):e68148. PubMed ID: 23874525
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.
    Zhenzhen L; Ning S; Xianghua L
    Tumour Biol; 2014 Jan; 35(1):433-40. PubMed ID: 23982872
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Single nucleotide polymorphisms of PIN1 promoter region and cancer risk: evidence from a meta-analysis.
    Peng JJ; Wei D; Li D; Fu ZQ; Tan Y; Xu T; Zhou JJ; Zhang T
    PLoS One; 2013; 8(8):e70990. PubMed ID: 23976970
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The -842G/C polymorphisms of PIN1 contributes to cancer risk: a meta-analysis of 10 case-control studies.
    Xu HR; Xu ZF; Sun YL; Han JJ; Li ZJ
    PLoS One; 2013; 8(8):e71516. PubMed ID: 24013949
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.
    Zhu YM; Liu JW; Xu Q; Yuan Y
    Asian Pac J Cancer Prev; 2013; 14(10):5965-72. PubMed ID: 24289610
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Functional polymorphism of PIN1 rs2233679 is associated with the progression of CIN to early cervical cancer in Hunan Chinese.
    Wang K; Fan J; Lin W; Zou C; He M; Cai Y; Pei H; Li M
    Taiwan J Obstet Gynecol; 2020 Mar; 59(2):220-226. PubMed ID: 32127141
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma.
    Lu Y; Huang GL; Pu XX; He YX; Li BB; Liu XY; Dong Z; He Z
    Mol Biol Rep; 2013 May; 40(5):3777-82. PubMed ID: 23269625
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population.
    You Y; Deng J; Zheng J; Jiang L; Li N; Wu H; Li W; Lu J; Zhou Y; Ni B
    Mol Biol Rep; 2013 Feb; 40(2):829-38. PubMed ID: 23054026
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations.
    Lu J; Yang L; Zhao H; Liu B; Li Y; Wu H; Li Q; Zeng B; Wang Y; Ji W; Zhou Y
    Hum Mutat; 2011 Nov; 32(11):1299-308. PubMed ID: 21850685
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
    Naidu R; Har YC; Taib NA
    Scand J Clin Lab Invest; 2011 Oct; 71(6):500-6. PubMed ID: 21745146
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.
    Han CH; Lu J; Wei Q; Bondy ML; Brewster AM; Yu TK; Buchholz TA; Arun BK; Wang LE
    Breast Cancer Res Treat; 2010 Jul; 122(1):243-9. PubMed ID: 20033770
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.
    Lu J; Hu Z; Wei S; Wang LE; Liu Z; El-Naggar AK; Sturgis EM; Wei Q
    Carcinogenesis; 2009 Oct; 30(10):1717-21. PubMed ID: 19625347
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.
    Lu KP; Zhou XZ
    Nat Rev Mol Cell Biol; 2007 Nov; 8(11):904-16. PubMed ID: 17878917
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Pin1 promoter polymorphisms in hepatocellular carcinoma patients.
    Segat L; Milanese M; Crovella S
    Gastroenterology; 2007 Jun; 132(7):2618-9; author reply 2619-20. PubMed ID: 17570241
    [No Abstract]   [Full Text] [Related]  

  • 118. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
    Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
    Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
    [TBL] [Abstract][Full Text] [Related]  

  • 119. PIN1 promoter polymorphisms are associated with Alzheimer's disease.
    Segat L; Pontillo A; Annoni G; Trabattoni D; Vergani C; Clerici M; Arosio B; Crovella S
    Neurobiol Aging; 2007 Jan; 28(1):69-74. PubMed ID: 16384626
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.